baber/WOPTO huggingface dataset:
Patent NO-942620-D0 (NO)
Inventor: BARNUM PAQUITA ERAZO
IPC: A23L29/206
Filed: 1994-07-12
Abstract: The present invention is a novel, water-insoluble, cation-complexed anionic polysaccharide that is readily dispersible into aqueous media to provide an ingestible composition having a low viscosity. An important aspect of the present invention is that it provides such compositions that are heat sterilizable. Furthermore, the water-insoluble, cation-complexed anionic polysaccharide of the present invention cause no or minor increases to the viscosity of such liquids that contain at least one member selected from the group consisting of proteins, peptides and amino acids. Another aspect of the invention concerns a method for administering an antidiarrheal composition to a human, said antidiarrheal composition comprising at least one water-insoluble, cation-complexed anionic polysaccharide dispersed in an aqueous medium. These compositions are useful as a nutritional means of improving gastrointestinal function including bowel function and increasing absorption of organic nutrients, inorganic nutrients and water by the gastrointestinal tract. In another aspect of the present invention is provided a novel method of preparing a water-insoluble, cation-complexed anionic polysaccharide comprising wetting a starting anionic polysaccharide with water to a total solids content of about 30 to 70%, adding a cation and then milling. In yet another aspect of the present invention is provided a composition comprising a water-insoluble, cation-complexed anionic polysaccharide. This invention also provides a low viscosity, feeding composition providing an individual's requirements for carbohydrates, proteins, lipids, vitamins, minerals and at least one substantially water-insoluble, cation-complexed anionic polysaccharide in an aqueous medium. This same composition may be prepared in a dehydrated state and then subsequently rehydrated when ready for use.
Patent NO-953087-D0 (NO)
Inventor: BURSELL MARTIN
IPC: C03C12/00
Filed: 1995-08-07
Abstract: The invention relates to a completely new white pigment of the inorganic sort, namely finely divided, preferably micronized, particles from transparent, coloured or uncoloured glass or mixtures of these, especially glass waste of the disposable type. The finely divided particles preferably have a size in the range of 0.01-10  mu m. The white pigment may, in accordance with the invention, be prepared by finely dividing, optionally after coarse crushing, transparent, coloured or uncoloured glass into such small particles that they are usable as white pigment. The invention also relates to a composition of matter comprising the new white pigment particles, especially a composition in the form of a paint. Finally, the invention relates to the use of said glass in finely divided form as white pigment.
Patent NO-954948-D0 (NO)
Inventor: BROADLEY MIKE
IPC: E05D3/02
Filed: 1995-12-06
Abstract: In the closed state of the lid (3) or the foldable side wall, both face ends of the spindle (4) are covered by the material (8) of the fixed container region (1) to which the lid or side wall is joined. The spindle is mounted to move between two end positions. The spindle is transversely movable on a straight or curved path. The container (1) has an aperture (7) through which the spindle can be inserted.
Patent NO-963880-D0 (NO)
Inventor: RISHOLM TORILL
IPC: B62B3/14
Filed: 1996-09-17
Abstract: A rack (14) for use in shopping carts (10), especially for use in grocery shops, comprises a support plate (15), which is fastened to the upper edge portion of the shopping cart (10) via one or more fastening means (16a, 16b). The plate (15) carries equipment for the display of goods in supply, advertising messages, and the like. The equipment comprises annular cover clips (21, 22) for the presentation of a pile of readily exchangeable, repageable sheets of offers on goods, for example current daily sheets of offers preferably received in separate plastic pockets or surrounded by plastic covers.
Patent NO-965357-D0 (NO)
Inventor: FUJIMOTO SADANARI
IPC: G11B7/013
Filed: 1996-12-13
Abstract: A test pattern area is provided outside the data area of an optical disk and recorded with a test pattern including a shortest pit row having repreated combinations of shortest pits and shortest non-pits, a longest pit row having repeated combinations of longest pits and longest non-pits, and a predetermined pit row having repeated combinations of pits with a predetermined pit length between said shortest pit length (mT) and said longest pit length (nT) and non pits corresponding to said pits. This test pattern data is reproduced by a reproducing system to detect an error rate, a compensation coefficient for minimizing the error rate is acquired, and a reproduction signal is compensated by using this compensation coefficient so that the reproduction signal is reproduced with the minimized error rate by the reproducing system. <IMAGE>
Patent NO-975008-D0 (NO)
Inventor: ROYO JOSE SANCHO
IPC: C08F10/00
Filed: 1997-10-30
Abstract: Catalyst component for the polymerisation of alpha-olefins of general formula (I) wherein:M is a transition metal of groups 3, 4-10, lanthanide or actinide of the periodic table of the elements; A is a ring with delocalized π electrons, L is a neutral Lewis base; m is an integer whose value can be: 0 or 1; E is selected from the group comprising: BR<sup>II</sup>, CR<sup>II</sup><sub>2</sub>, SiR<sup>II</sup><sub>2</sub>, GeR<sup>II</sup><sub>2</sub>; Hal is selected from the group comprising iodine, bromine or chlorine; R<sup>III</sup> has the same meaning of R<sup>II</sup>; Si is a silicon atom; D is selected from the group comprising: O, S, NR<sup>IV</sup>, PR<sup>IV</sup>, OR<sup>IV</sup>, SR<sup>IV</sup>, NR<sup>IV</sup><sub>2</sub>, PR<sup>IV</sup><sub>2</sub>; each X group equal to or different from each other is selected from the group comprising hydrogen, halide, alkyl, cycloalkyl, aryl, alkenyl, arylalkyl, arylalkenyl or alkylaryl with 1 to 20 carbon atoms, n is a number whose value can be: 0, 1, 2 or 3, in order to full the remaining valences of metal M. It is also described a method for supporting the compound of formula I.
Patent NO-980245-D0 (NO)
Inventor: NAKAGAMI HIROAKI
IPC: A61K9/32
Filed: 1998-01-20
Abstract: A granular preparation comprising particles prepared by melt granulation of a powdered low-melting oily substance and a powdered medicine, the particles being coated with a finely powdered hydrophobic and oil-absorbing high polymeric compound (if desired, together with a finely powdered diluent) by melt coating, and a producing process thereof. The preparation does not cake even under heat and humid conditions and is effective for masking bitterness of a medicine.
Patent NO-993600-D0 (NO)
Inventor: WEINER HOWARD L
IPC: A61P19/04
Filed: 1999-07-23
Abstract: A combination of a mucosally administrable bystander antigen and an orally, enterally, or parenterally administrable methotrexate is employed to make a pharmaceutical formulation and to treat or prevent autoimmune disease. The amounts of bystander antigen and methotrexate are effective in combination to suppress autoimmune response associated with the autoimmune disease.
Patent NO-993953-D0 (NO)
Inventor: LINDQVIST BJOERN H
IPC: C07K14/01
Filed: 1999-08-17
Abstract: The present invention relates to methods of producing peptide or protein expression libraries. In such a library, a population of nucleotide sequences is expressed. The resulting peptides or proteins encoded by those nucleotide sequences are then screened to identify those peptides or proteins having a desired property such as the ability to bind a selected ligand. In the construction and screening of such libraries, it is desired to ensure that the nucleotide encoding a particular protein remains connected in some way with that protein so that once a desired protein having a selected property has been isolated, its encoding nucleotide sequence may be specifically recovered for subsequent manipulation for example using PCR or sequencing. The present invention makes use of a property not previously described in constructing an expression library namely the use of proteins which covalently bind DNA. DNA is expressed in such a way that the protein so expressed binds to its own encoding DNA therefore allowing the DNA to be associated only with its encoding protein.
Patent GB-0031079-D0 (GB)
Title: Vaccine
IPC: A61K47/48
Filed: 2000-12-20
Abstract: The present invention provides active or passive forms of immunotherapy against the metabolites of nicotine. For example, there is provided a vaccine comprising a metabolite of nicotine, and in particular those vaccines that comprise cotinine, which is used for immunotherapy of nicotine addiction.
Patent GB-0129989-D0 (GB)
Title: Improvements in or relating to mobile location devices and methods
IPC: H04L12/56
Filed: 2001-12-14
Abstract: A mobile location device comprising geographical location circuitry to provide device geographical location information and motion detection circuitry to detect motion of the device, wherein the geographical location circuitry is arranged to provide device geographical location information according to whether motion of the mobile location device is detected by the motion detecting circuitry.
Patent GB-0230107-D0 (GB)
Title: Combined exerciser/massage device
IPC: A63B23/04
Filed: 2002-12-24
Abstract: A combined exerciser/massage device includes a base 1, a shaft 11 rotatably mounted to the base 1, two cranks 2 respectively mounted to two ends of the shaft 11, and two pedals 21 respectively mounted to the cranks 2. Each pedal 21 has at least one massage member 22 provided thereon for massaging a sole of a user's foot on the pedal. Two legrests 3 are provided on the base and each has at least one massage member 30 provided thereon for massaging one of a calf and a ham of a user's leg that is cycling an associated one of the pedals. The legrests 3 may be mounted on the end of a rod pivotable fixed to the base 1 to allow the legrests to be adjusted to a desired position.
Patent GB-0308557-D0 (GB)
Title: A mechanism for securing an eye protector to a helmet
IPC: A42B3/22
Filed: 2003-04-12
Abstract: A mechanism for securing an eye protector 8 to a helmet comprises an arcuate frame 3 and attachment means at each end thereof. Each attachment means comprises a bracket 31 integral to the arcuate frame and a separate engagement body 4. At the upper end of each bracket there is provided an inner raised round surface 32 having first radial ridges 33, an outer recessed round surface 34 and a central hole 35. Each engagement body 4 comprises an upper round surface having second radial ridges 41 and central hole 42 and a lower latch part having two resilient latch pieces 43. The engagement bodies 4 are secured to the brackets 31 using fastening means such as a threaded bolt 5. The latch parts are then inserted into recesses (11, Fig 3) located on each side of the helmet, and the eye protector attached to the arcuate frame, is rotatable into set positions due to the first and second radial ridges interlocking.
Patent GB-0412893-D0 (GB)
Title: Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
IPC: C07D257/00
Filed: 2004-06-10
Abstract: A compound of Formulae (1), (2) or (3), A1-Ph (1) or A1-Ar-A2 (2) or A1-(A2)A′-A3 (3) wherein A1, A2 and A3 are selected from Formulae 4, 5 and 6: or a salt whereof; wherein Ar is selected from the group consisting of 1,2-phenyl, 1,3-phenyl and 1,4-phenyl optionally substituted with one or more methyl groups; m and n are independently integers from 0 to 1; Ph is phenyl, optionally substituted with one or more methyl groups; Ar1 is trisubstituted phenyl optionally substituted with one or more phenyl groups; and R1, R2 and R3 are independently selected from the group consisting of H, Me and linear chain C2-C4 alkyl.
Patent GB-0500510-D0 (GB)
Title: Retentive and removable trial beaaring inser
IPC: A61F2/46
Filed: 2005-01-11
Abstract: A retentive and removable trial bearing insert for use with a total hip replacement joint which includes a dual mobility or bipolar prosthetic cup which has a part-spherical bearing insert with a part-spherical inner bearing surface which engages a part-spherical bearing head on a femoral stem, comprises a part-spherical trial inner bearing element (1) dimensioned to replace the part-spherical bearing insert and which includes releasable retaining means (2) which engage the bearing head of the femoral stem or a trial bearing head thereof to hold the trial bearing element in place thereon.
Patent GB-0522412-D0 (GB)
Title: Fragrance compositions comprising benzo[4,5]thieno[3,2-B]pyran-2-one
IPC: C12H6/02
Filed: 2004-04-08
Abstract: The present case discloses compositions of benzo[4,5]thieno[3,2-b]pyran-2-one which are employed as aroma chemicals.
Patent GB-0614910-D0 (GB)
Title: Advanced safety harness for child seat
Filed: 2006-07-26
Abstract: The present invention concerns a child seat having an advanced safety harness (20). The safety harness (20) has an upper body restraining strap configuration (35) and a lower body restraining strap configuration (36), with the lower body restraining strap configuration (36) having upper strap supply points (24) on the child seat back (22) which are separate from upper strap supply points (21) of the upper body restraining strap configuration (35). As such, the occupant's upper and lower body can be restrained substantially separately in the event of an accident.
Patent GB-0625283-D0 (GB)
Title: Combination
Filed: 2006-12-19
Abstract: A first aspect of the invention relates to a combination comprising 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine, or a metabolite thereof, or a pharmaceutically acceptable salt thereof, and a cytotoxic agent selected from: (a) a HDAC inhibitor; and (b) a topoisomerase inhibitor selected from etoposide, topotecan and SN-38, or a prodrug thereof. A second aspect relates to a pharmaceutical product comprising (i) 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine, or a metabolite thereof, or a pharmaceutically acceptable salt thereof, and (ii) a cytotoxic agent selected from: (a) a HDAC inhibitor; and (b) a topoisomerase inhibitor selected from etoposide, topotecan and SN-38, or a prodrug thereof, as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect relates to a method of treating a proliferative disorder, said method comprising simultaneously, separately or sequentially administering to a subject 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine, or a metabolite thereof, or a pharmaceutically acceptable salt thereof, and a cytotoxic agent selected from: (a) a HDAC inhibitor; and (b) a topoisomerase inhibitor selected from etoposide, topotecan and SN-38, or a prodrug thereof. A fourth aspect of the invention relates to the use of a subject 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine, or a metabolite thereof, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for treating cutaneous T-cell lymphoma (CTCL).
Patent GB-0708203-D0 (GB)
Title: Scheduliing information method and related communications devices
IPC: H04W72/12
Filed: 2007-04-27
Abstract: In a method of providing scheduling information for use at the mobile radio communications network device for UL resource allocation at the mobile radio communications device between a plurality of Radio Bearers, wherein each Radio Bearer has a Prioritized Bit Rate and at least one Radio Bearer comprises a Guaranteed Bit Rate Radio Bearer. The mobile radio communications device estimates the average bit rate transmitted for each of the plurality of Radio Bearers over a time period and generates rate control data responsive to determination of one or more of the following parameters: for each Guaranteed Bit Rate Radio Bearer whether a maximum Bit Rate has been reached; for each Guaranteed Bit Rate Radio Bearer whether the Prioritized Bit Rate has been reached; whether one or the Guaranteed Bit Rate Radio Bearers has been served during the said time period; whether a total estimated data rate for at least one Guaranteed Bit Rate Radio Bearer does not exceed an Aggregate Maximum Bit Rate value; for each Non-Guaranteed Bit Rate Radio Bearer whether the Prioritized Bit Rate is achieved; whether at least one Non-Guaranteed Bit Rate Radio Bearer is served during the said time period.
Patent GB-0715623-D0 (GB)
Title: Injection devices
Filed: 2007-08-10
Abstract: An injection device has a main drive module which can be screwed into the back of a syringe housing to prepare the injector ready for use. The drive module has a firing button and a drive plunger released for forward movement by pressing the firing button. The syringe housing slideably receives a syringe holder whose forward movement is initially prevented by internally directed barbs on a cylindrical latching sleeve. The latching sleeve is acted upon by a release ring on the drive module such that as the drive module is screwed onto the syringe housing, the release ring splays the cylindrical shell to release the syringe carrier for forward movement. The barbs also act as a latch to capture the syringe carrier in its rearward position when the drive module is unscrewed from the syringe housing, which returns the barbs to their initial position before the syringe holder returns to its initial position.
Patent GB-0719207-D0 (GB)
Title: Telecommunications network
Filed: 2007-10-02
Abstract: A method is disclosed for method for reducing signalling between a mobile terminal and a cellular communications network having at least a first bearer technology and a second bearer technology. The method comprise: performing an initial location registration event between the mobile terminal and the cellular communications network; storing session management state data when the terminal enters a state in which the terminal is simultaneously registered with the network over the first and second bearer technologies; when the active bearer technology is changed from the first bearer technology to the second bearer technology, determining the current session management state data and comparing the stored session management state data to the current session management state data; and if the stored session management state data and current session management state data are different, triggering a further location registration event.
Patent GB-0906680-D0 (GB)
Title: A low-k material
Filed: 2009-04-17
Abstract: There is disclosed a method for producing a highly cross-linked polypropylene material by plasma polymerisation of a carbon containing gas, not specifically propylene, exhibiting low relative permittivity, high thermal stability and enhanced mechanical properties, said method and material being suitable for application not limited to interlayer dielectric deposition in microchip fabrication.
Patent GB-8705954-D0 (GB)
Title: Plastics structures
IPC: C08J5/04
Filed: 1987-03-13
Abstract: An air permeable sheet-like structure comprising 5% to 50% by weight of reinforcing fibres (1) which are between about 5 and about 50 millimetres long, and from 50% to 95% by weight of wholly or substantially unconsolidated particulate non-cross-linked elastomeric material (3), and in which the fibrous (1) and elastomeric components (3) are bonded (2) into an air permeable structure.
Patent GB-8706401-D0 (GB)
Title: Genetic probes
IPC: C12Q1/68
Filed: 1987-03-18
Abstract: Test samples of genomic DNA may be characterized by the use of polynucleotide probes each of which is specific for an informative genetic locus. Such probes may be prepared by the use of probes which are capable of differentiating DNA by reference to more than one polymorphic minisatellite region or hypervariable locus. The polynucleotides and probes of the invention are of use for genetic identification purposes, paternity and maternity testing and particularly in forensic medicine.
Patent GB-8800585-D0 (GB)
Title: Thermotropic polymer compositions
IPC: C08L67/04
Filed: 1988-01-12
Abstract: A thermoplastic polymer composition comprising a thermotropic polymer and 0.025 to 5% by weight of the composition of a finely dispersed particulate inorganic additive wherein the additive is a material having at least 95% by weight of particles with at least one dimension less than 1 micron and preferably less than 0.1 micron and is an organophilic or organophobic material which has a settling volume of at least 10 when measured in a liquid in which the particulate material is compatible. The presence of the inorganic additive in the thermotropic polymer gives rise to an improved processing behaviour.
Patent GB-9312797-D0 (GB)
Title: Bandage
IPC: A61F13/02
Filed: 1991-12-24
Abstract: A bandage (100) having a first member (120) of elastic material (14) covered by woven material (150) and a second member of inelastic material (160, 165) with hooked elements (170) which engage the woven material of the first member. The second member may be used to fasten (165) the first member or to provide inelastic regions (160) on the first member for support etc. Slits (180, 185) or apertures (190) may be introduced to the first member to increase the scope of use of the bandage.
Patent GB-9515476-D0 (GB)
Title: Stapler
IPC: B27F7/38
Filed: 1995-07-28
Abstract: The stapler comprises a magazine, a channel member for staples, the channel member being guided in the magazine and lockable at one end of it in a retracted setting in the magazine and release device to unlock the channel member. It also has a resilient spring to urge the channel member when unlocked out of the magazine. It has a damper arranged in the region of the one end of the channel member to reduce the speed of movement of the member out of the magazine. The damper comprises a brake roller mounted in the channel member. The roller is mounted in a respective groove in each side flange of the channel member.
Patent GB-9716365-D0 (GB)
Title: Improvements in or relating to magnetic resonance imaging
IPC: G01R33/563
Filed: 1997-08-01
Abstract: This invention relates to a method of contrast agent-enhanced magnetic resonance imaging of perfusion in vasculated tissue within a human or non-human animal body in which a bolus comprising a contrast-enhancing amount of a magnetic resonance imaging contrast agent is administered into the vascular system of said body, and said body is subjected to a magnetic resonance imaging procedure whereby signals or images representative of first pass of said contrast agent bolus through tissue of interest are generated, characterised in that (i) said contrast agent is capable of exhibiting simultaneous, determinable T1 and T2* reducing effects under the imaging procedure employed and (ii) a T1-weighted imaging procedure is used (a) to visualise the first pass of said contrast agent bolus through said tissue by virtue of its signal lowering T2* effect and (b) to obtain a T1-weighted contrast agent-enhanced image of said tissue.
Patent GB-9906618-D0 (GB)
Title: Compositions
IPC: C08G18/60
Filed: 1999-03-23
Abstract: An aqueous crosslinkable coating composition comprising i) an autoxidisably crosslinkable polymer, ii) a not autoxidisably crosslinkable vinyl polymer bearing carbonyl groups and iii) carbonyl-reactive groups to crosslink the vinyl polymer.
Patent GB-9919404-D0 (GB)
Title: Aperture closures
IPC: E05F15/16
Filed: 1999-08-18
Abstract: A sliding door mechanism controls a door 10 in the form of a series of horizontal slats articulated to the slats above and below to move from a closed position in a vertical plane, along between tracks 14, until open. The door is moved by cables winding on or off a cable drum 12 driven through a drive belt 16 by an electric motor 18. The motor is on a carriage mounted at 30 to allow the drive belt to be slackened to remove drive from the drum 12. Control circuits 20 for the apparatus are described. <IMAGE>